HUE061954T2 - Vastagbél tisztítására és gyomor-bélrendszeri rendellenességek kezelésére szolgáló készítmények - Google Patents

Vastagbél tisztítására és gyomor-bélrendszeri rendellenességek kezelésére szolgáló készítmények

Info

Publication number
HUE061954T2
HUE061954T2 HUE16721609A HUE16721609A HUE061954T2 HU E061954 T2 HUE061954 T2 HU E061954T2 HU E16721609 A HUE16721609 A HU E16721609A HU E16721609 A HUE16721609 A HU E16721609A HU E061954 T2 HUE061954 T2 HU E061954T2
Authority
HU
Hungary
Prior art keywords
compositions
treatment
gastrointestinal disorders
colon cleansing
cleansing
Prior art date
Application number
HUE16721609A
Other languages
English (en)
Hungarian (hu)
Inventor
Mark Currie
Robert Solinga
Christopher Leitheiser
Original Assignee
Ironwood Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ironwood Pharmaceuticals Inc filed Critical Ironwood Pharmaceuticals Inc
Publication of HUE061954T2 publication Critical patent/HUE061954T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HUE16721609A 2015-05-01 2016-04-29 Vastagbél tisztítására és gyomor-bélrendszeri rendellenességek kezelésére szolgáló készítmények HUE061954T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562156077P 2015-05-01 2015-05-01

Publications (1)

Publication Number Publication Date
HUE061954T2 true HUE061954T2 (hu) 2023-09-28

Family

ID=55953439

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE16721609A HUE061954T2 (hu) 2015-05-01 2016-04-29 Vastagbél tisztítására és gyomor-bélrendszeri rendellenességek kezelésére szolgáló készítmények

Country Status (23)

Country Link
US (2) US10618938B2 (enExample)
EP (2) EP4218789A3 (enExample)
JP (5) JP6930919B2 (enExample)
KR (2) KR102783759B1 (enExample)
CN (2) CN114716514A (enExample)
CA (2) CA2984437C (enExample)
CY (1) CY1126031T1 (enExample)
DK (1) DK3288578T5 (enExample)
EA (1) EA201792401A1 (enExample)
ES (1) ES2947591T3 (enExample)
FI (1) FI3288578T3 (enExample)
HR (1) HRP20230381T1 (enExample)
HU (1) HUE061954T2 (enExample)
LT (1) LT3288578T (enExample)
MA (1) MA41985B1 (enExample)
MD (1) MD3288578T2 (enExample)
MX (2) MX2017013928A (enExample)
PL (1) PL3288578T3 (enExample)
PT (1) PT3288578T (enExample)
RS (1) RS64160B1 (enExample)
SI (1) SI3288578T1 (enExample)
SM (1) SMT202300114T1 (enExample)
WO (1) WO2016178979A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102783759B1 (ko) * 2015-05-01 2025-03-21 아이언우드 파마슈티컬스, 인코포레이티드 결장 세정을 위한 조성물 및 위장 장애의 치료
SMT202200173T1 (it) 2016-06-01 2022-05-12 Athira Pharma Inc Composti
EP4436980A1 (en) * 2021-11-24 2024-10-02 Ironwood Pharmaceuticals, Inc. Synthetic process for production of modified gcc receptor agonists
MX2024006317A (es) * 2021-11-24 2024-06-19 Ironwood Pharmaceuticals Inc Proceso sintetico para la produccion de agonistas del receptor de guanilato ciclasa c (gcc) modificados.
EP4440595A1 (en) * 2021-11-29 2024-10-09 Ironwood Pharmaceuticals, Inc. Pharmaceutical compositions for the treatment of visceral pain

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH689139A5 (de) 1995-04-03 1998-10-30 Cerbios Pharma Sa Verfahren zur Herstellung einer liposomalen, in Wasser dispergierbaren, oral zu verabreichenden, festen, trockenen therapeutischen Formulierung.
US5912014A (en) 1996-03-15 1999-06-15 Unigene Laboratories, Inc. Oral salmon calcitonin pharmaceutical products
DE602004028678D1 (de) * 2003-01-28 2010-09-23 Ironwood Pharmaceuticals Inc Zusammensetzungen zur Behandlung von Magen-Darm-Störungen
US7494979B2 (en) * 2003-06-13 2009-02-24 Ironwood Pharmaceuticals, Inc. Method for treating congestive heart failure and other disorders
CA2619650A1 (en) * 2005-08-19 2007-02-22 Microbia, Inc. Methods and compositions for the treatment of gastrointestinal disorders
EP2331561A4 (en) * 2008-09-03 2013-02-27 Xenome Ltd PEPTIDE CONJUGATE LIBRARIES AND METHODS OF MAKING SAME
WO2011103311A2 (en) * 2010-02-17 2011-08-25 Ironwood Pharmaceuticals, Inc Treatments for gastrointestinal disorders
KR102034748B1 (ko) * 2011-03-01 2019-10-21 시너지 파마슈티컬즈 인코포레이티드 구아닐레이트 사이클라제 c 작용제의 제조 방법
EP3718557A3 (en) 2013-02-25 2020-10-21 Bausch Health Ireland Limited Guanylate cyclase receptor agonist sp-333 for use in colonic cleansing
EP4424697A3 (en) * 2013-06-05 2024-12-25 Bausch Health Ireland Limited Ultra-pure agonists of guanylate cyclase c, method of making and using same
WO2016015055A1 (en) * 2014-07-25 2016-01-28 Ironwood Pharmaceuticals, Inc. Colon cleansing compositions
KR102783759B1 (ko) * 2015-05-01 2025-03-21 아이언우드 파마슈티컬스, 인코포레이티드 결장 세정을 위한 조성물 및 위장 장애의 치료

Also Published As

Publication number Publication date
RS64160B1 (sr) 2023-05-31
FI3288578T3 (fi) 2023-05-03
JP2025169325A (ja) 2025-11-12
DK3288578T3 (da) 2023-05-01
JP2022121734A (ja) 2022-08-19
SMT202300114T1 (it) 2023-05-12
WO2016178979A1 (en) 2016-11-10
HRP20230381T1 (hr) 2023-07-07
CA2984437C (en) 2025-11-18
LT3288578T (lt) 2023-04-25
US20180148476A1 (en) 2018-05-31
BR112017023539A2 (pt) 2018-08-14
EA201792401A1 (ru) 2018-05-31
KR20250042844A (ko) 2025-03-27
CN108040482B (zh) 2022-03-29
KR102783759B1 (ko) 2025-03-21
SI3288578T1 (sl) 2023-07-31
JP6930919B2 (ja) 2021-09-01
MA41985B1 (fr) 2023-04-28
JP2024015335A (ja) 2024-02-01
CN108040482A (zh) 2018-05-15
CA2984437A1 (en) 2016-11-10
ES2947591T3 (es) 2023-08-11
CA3172777A1 (en) 2016-11-10
EP3288578A1 (en) 2018-03-07
MA41985A (fr) 2018-03-07
MX2017013928A (es) 2018-01-15
PL3288578T3 (pl) 2023-08-14
MX2022013283A (es) 2022-12-13
PT3288578T (pt) 2023-03-28
EP4218789A3 (en) 2023-09-27
KR20180005675A (ko) 2018-01-16
EP3288578B8 (en) 2023-03-29
US10618938B2 (en) 2020-04-14
EP4218789A2 (en) 2023-08-02
EP3288578B1 (en) 2023-03-15
CN114716514A (zh) 2022-07-08
MD3288578T2 (ro) 2023-08-31
US20240199697A1 (en) 2024-06-20
CY1126031T1 (el) 2023-11-15
JP2018519254A (ja) 2018-07-19
DK3288578T5 (da) 2024-10-07
JP2020203954A (ja) 2020-12-24

Similar Documents

Publication Publication Date Title
IL289650A (en) Azolopyrimidine for the treatment of cancer-related disorders
IL273693A (en) Treatment of inflammatory disorders
IL246833A0 (en) New salts and their pharmaceutical preparations for the treatment of inflammatory disorders
IL255109A0 (en) New dihydropyridoisoquinolinones and their pharmaceutical preparations for the treatment of inflammatory disorders
GB201402070D0 (en) Pharmaceutical compositions for the treatment of inflammatory disorders
IL262348A (en) Preparations for the treatment of excessive radiation disorders
GB201411241D0 (en) Novel dihydropyridoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GB201608046D0 (en) Treatment of complement-mediated disorders
IL258032A (en) Compounds and preparations for the treatment of ocular disorders
GB201401086D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GB201610056D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders and osteoarthritis
PL3348273T3 (pl) Kompozycje na bazie ksyloglukanu i białek do leczenia zaburzeń jelitowych
HUE061954T2 (hu) Vastagbél tisztítására és gyomor-bélrendszeri rendellenességek kezelésére szolgáló készítmények
GB201610055D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders and osteoarthritis
GB201607388D0 (en) Treatment of impulsivity-related disorders
ZA201706985B (en) Compositions for the treatment of fibrosis and fibrosis-related conditions
ZA201903222B (en) Compositions and methods for the treatment of gastrointestinal polyps
SG11201706952VA (en) Compositions and methods for the treatment of epilepsy and neurological disorders
IL254140A0 (en) Preparations and combinations for use in the treatment of angiogenic diseases and disorders
GB201602784D0 (en) New treatment of CFTR-related disorders
IL247170A0 (en) Colon lavage method